- Home
- CYCC vs NEUE Comparison
CYCC vs NEUE Comparison
Compare CYCC & NEUE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CYCC
- NEUE
- Stock Information
- Founded
- CYCC 1992
- NEUE 2015
- Country
- CYCC Malaysia
- NEUE United States
- Employees
- CYCC N/A
- NEUE N/A
- Industry
- CYCC Biotechnology: Pharmaceutical Preparations
- NEUE
- Sector
- CYCC Health Care
- NEUE
- Exchange
- CYCC Nasdaq
- NEUE NYSE
- Market Cap
- CYCC 61.2M
- NEUE 61.2M
- IPO Year
- CYCC N/A
- NEUE 2021
- Fundamental
- Price
- CYCC $1.63
- NEUE $6.87
- Analyst Decision
- CYCC
- NEUE Hold
- Analyst Count
- CYCC 0
- NEUE 1
- Target Price
- CYCC N/A
- NEUE $7.00
- AVG Volume (30 Days)
- CYCC 191.0K
- NEUE 7.2K
- Earning Date
- CYCC 05-15-2025
- NEUE 05-08-2025
- Dividend Yield
- CYCC 147.24%
- NEUE N/A
- EPS Growth
- CYCC N/A
- NEUE N/A
- EPS
- CYCC N/A
- NEUE N/A
- Revenue
- CYCC $14,000.00
- NEUE $907,349,000.00
- Revenue This Year
- CYCC $137.21
- NEUE $33.99
- Revenue Next Year
- CYCC N/A
- NEUE $5.90
- P/E Ratio
- CYCC N/A
- NEUE N/A
- Revenue Growth
- CYCC N/A
- NEUE N/A
- 52 Week Low
- CYCC $1.36
- NEUE $3.79
- 52 Week High
- CYCC $49.34
- NEUE $7.66
- Technical
- Relative Strength Index (RSI)
- CYCC 32.89
- NEUE 54.74
- Support Level
- CYCC $1.36
- NEUE $6.66
- Resistance Level
- CYCC $1.94
- NEUE $6.89
- Average True Range (ATR)
- CYCC 0.43
- NEUE 0.12
- MACD
- CYCC -0.07
- NEUE -0.01
- Stochastic Oscillator
- CYCC 8.31
- NEUE 72.41
About CYCC Cyclacel Pharmaceuticals Inc.
Cyclacel Pharmaceuticals Inc is a clinical-stage biopharmaceutical company that develops targeted medicines for cancer and other proliferative diseases. The company develops several families of anticancer drugs that act on the cell cycle, including CDK (cyclin-dependent kinase) inhibitors and PLK (polo-like kinase) inhibitors. The pipeline development programs of the company include fadraciclib and plogosertib.
About NEUE NEUEHEALTH INC
NeueHealth Inc is a value-driven healthcare company grounded in the belief that all health consumers are entitled to high-quality, coordinated healthcare. It consists of two reportable segments: NeueCare - it's a value-driven care delivery business that manages risk in partnership with external payors and serves all populations across The Patient Protection and Affordable Care Act and the Health Care and Education Reconciliation Act. NeueSolutions - it's a provider enablement business that includes a suite of technology, services, and clinical care solutions that empower providers to thrive in performance-based arrangements.